Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $49.8358 (-2.21%) ($48.8810 - $51.5134) on Thu. Jan. 28, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.62% (three month average) | RSI | 49 | Latest Price | $49.8358(-2.21%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.9% a day on average for past five trading days. | Weekly Trend | ABBV advances 3.3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Rotation from growth to value for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(62%) VYM(48%) IVE(47%) IBB(46%) IWD(46%) | Factors Impacting ABBV price | ABBV will decline at least -1.31% in a week (0% probabilities). VIXM(-20%) TLT(-14%) UUP(-10%) IGOV(-3%) GLD(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.31% (StdDev 2.62%) | Hourly BBV | 0 () | Intraday Trend | -2.4% | | | |
|
Resistance Level | $50.42 | 5 Day Moving Average | $51.52(-3.27%) | 10 Day Moving Average | $50.99(-2.26%) | 20 Day Moving Average | $50.42(-1.16%) | To recent high | -12% | To recent low | 9.1% | Market Cap | $87.924b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |